MP
VHAQ.RT

Mangrove Partners’s Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock VHAQ.RT Stock Holding History

Mangrove Partners’s Portfolio VHAQ.RT Stock Details VHAQ.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-118,161
Closed -$7.09K – 198
2023
Q4 		$7.09K Hold
118,161
– – ﹤0.01% 175
2023
Q3 		$7.17K Hold
118,161
– – ﹤0.01% 166
2023
Q2 		$6.77K Hold
118,161
– – ﹤0.01% 216
2023
Q1 		$5.91K Sell
118,161
-337,648
-74% -$30.4K ﹤0.01% 246
2022
Q4 		$59.4K Sell
455,809
-17,133
-4% -$2.14K ﹤0.01% 342
2022
Q3 		$57K Hold
472,942
– – ﹤0.01% 367
2022
Q2 		$38K Hold
472,942
– – ﹤0.01% 514
2022
Q1 		$57K Buy
+472,942
New +$75.5K ﹤0.01% 449

Other funds holding VHAQ.RT

SIA
SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return

Mangrove Partners's VHAQ.RT Position: Q1 2024 in Review

Mangrove Partners sold out of Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock (VHAQ.RT) in Q1 2024, closing a stake of 118,161 shares — an estimated $7.09K sold.

Mangrove Partners first reported a position in VHAQ.RT in Q1 2022 and held it in 8 quarters. The position peaked at $59.4K in Q4 2022. 5 funds tracked by Wall St. Rank hold VHAQ.RT as of Q1 2024.

  • Mangrove Partners reported no remaining Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock position as of Q1 2024 after selling out during the quarter.
  • Mangrove Partners sold 118,161 Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock shares in Q1 2024, an estimated $7.09K.
  • Mangrove Partners first reported a position in Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock in Q1 2022 and held it in 8 quarters.
  • Mangrove Partners's Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock position peaked at $59.4K in Q4 2022.
  • 5 funds tracked by Wall St. Rank held Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock as of Q1 2024.

Based on Mangrove Partners's 13F filing for Q1 2024, filed 15 May 2024.